Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Prostaglandins, Leukotrienes, and Medicine|November 1, 1986
Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-lifeE Strobl-Jäger, K Widhalm, H SinzingerActa Histochemica|January 1, 1985
[A semiquantitative method of determining alkaline phosphatase activity in human arterial wall]E Strobl-Jäger, W Firbas, H SinzingerProstaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H SinzingerEuropean Journal of Nuclear Medicine|January 1, 1984
A simple and safe technique for sterile autologous platelet labelling using "Monovette" vialsH Sinzinger, H Kolbe, E Strobl-Jäger, et al.Wiener Klinische Wochenschrift|February 5, 1988
[Technic and clinical use of radioactive labelling of autologous granulocytes]E Strobl-Jäger, H Kolbe, H Ludwig, et al.Prostaglandins, Leukotrienes, and Medicine|March 1, 1985
The prostacyclin synthesis stimulating plasma factor is unchanged during acute angina pectorisH Sinzinger, J Kaliman, P Fitscha, et al.Prostaglandins, Leukotrienes, and Medicine|August 1, 1987
Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular diseaseE Strobl-Jäger, P Fitscha, J Kaliman, et al.Prostaglandins, Leukotrienes, and Medicine|May 1, 1986
Prostacyclin synthesis stimulating plasma factor in patients with primary hyperlipoproteinemia--effect of dietary and drug treatmentH Sinzinger, J Kaliman, E Strobl-Jäger, et al.Pageof 1